News

Muscular Dystrophy Association Gathers Global Leaders at Annual Conference, the Largest Convening in the Field of Neuromuscular Disease Research & Care in the World

NEW YORK, Feb. 9, 2022 /PRNewswire/ -- The Muscular Dystrophy Association (MDA) announced today the schedule for the 2022 MDA Clinical &...

Jaguar Health Completes Final Major Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea in Dogs

Canalevia™ would be first and only FDA-approved plant-based medicine for working dogs that suffer from diarrheaSAN FRANCISCO, CA / ACCESSWIRE...

CureVac Doses First Participant in Phase 1 Study with Multivalent Influenza Vaccine Candidate Based on Second-Generation mRNA Backbone Developed in Collaboration with GSK

- Multivalent technology approach for seasonal influenza mRNA vaccine candidate addressing four different influenza strains- Influenza candidate developed in collaboration...

error: Content is protected !!